Back to results
US 12,605,468 B2Granted
Oxazine-based fluorophore compounds for nerve-specific imaging
AssigneeOregon Health & Science University
InventorsSummer L. Gibbs, Lei G. Wang, Connor W. Barth
Life of this patent
Estimating the term…
Abstract
This invention concerns novel oxazine-based fluorophore compounds useful in in vivo nerve imaging, as well as compositions comprising them and methods for their use.
Claims11
A compound of Formula (II):
- wherein:
- R1 is selected from the group consisting of a straight or branched C1-C6 alkyl;
- —(CH2)n1—SO3−;
- —(CH2)n1—N+(CH3)3;
- —CH2—CH2—O—X1;
- —CH2—CH2—O—[CH2—CH2—O]n2—X1;
- —CH2—CH2—CH2—O—X1;
- and —CH2—CH2—CH2—O—[CH2—CH2—CH2—O]n3—X1;
- or a moiety selected from the group consisting of:
- R4 and R5, together with the nitrogen atom to which they are bound, form a ring selected from the group consisting of:
- R6 is hydrogen;
- X1 in each instance is independently selected from the group consisting of C1-C6 straight or branched alkyl, C1-C6 straight or branched alkenyl, C1-C6 straight or branched alkynyl, and —Si(C1-C4 alkyl)3;
- n is an integer selected from the group of 1 and 2;
- n1 is an integer independently selected in each instance from the group consisting of 1, 2, 3, and 4;
- n2 is an integer independently selected in each instance from the group consisting of 1, 2, 3, 4, 5, 6, 7, 8, 9, and 10;
- n3 is an integer independently selected in each instance from the group consisting of 1, 2, 3, 4, 5, 6, 7, 8, 9, and 10;
- n4 is an integer independently selected in each instance from the group consisting of 1, 2, 3, 4, 5, 6, 7, 8, 9, and 10;
- and
- with the proviso that the sum of n2+n2 is not greater than 10;
- with the proviso that the sum of n2+n3 is not greater than 10;
- with the proviso that the sum of n2+n4 is not greater than 10;
- and
- with the proviso that the sum of n3+n4 is not greater than 10.
20 more elements
Dependencies are inferred from the claim text.